The Hematology/Oncology Fellowship at Washington University School of Medicine is proud to announce that third-year fellow, Stefan Tarnawsky, M.D., Ph.D, has been selected by the American Society of Hematology (ASH) to participate in the 2024 Research Training Award for Fellows (RTAF). He is one of 17 outstanding fellows across the country selected for this highly competitive award, and one of two fellows selected within the fellowship program. Stefan will receive $70,000 in funding to carry out a hematology research project throughout the program’s duration from July 1, 2024 to June 30, 2025. He will also receive a $1,000 travel stipend the year after the award to attend the ASH annual meeting.
“I am honored to be one of two WashU Heme/Onc fellows to have been selected for the ASH RTAF – go Giulia! It is a testament to the supportive mentoring environment within our fellowship program that we were both able to receive this prestigious award,” comments Stefan.
Stefan’s research focuses on myelodysplastic syndromes driven by mutations in U2AF1, a gene encoding a splicing factor. His RTAF project will study mutant U2AF1 expression in mouse and human blood progenitors, with the aim of exploring potential interventions that can overcome mutant U2AF1-induced growth defects. He is being mentored by Dr. Matt Walter, M.D., Ph.D.